Could less be more? new study tests safer dosing for heart surgery patients
NCT ID NCT07477977
First seen Mar 18, 2026 · Last updated May 10, 2026 · Updated 8 times
Summary
This study looks at whether giving a lower dose of protamine (a drug that reverses the blood thinner heparin) after heart-lung bypass is safe and effective. About 195 adults having planned heart surgery will be randomly assigned to one of three protamine doses. The goal is to see if a lower dose can still reverse heparin well while causing fewer side effects like bleeding or unstable blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN HEART SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sohag University Hospital
RECRUITINGSohag, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.